Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder - Wikidata - awgldk - TriplyDB

Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder

Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder

http://www.wikidata.org/entity/Q34451408

about

Neuroplasticity and the next wave of antidepressant strategies mTOR activation is required for the antidepressant effects of mGluR₂/₃ blockade Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial The Addictive Model of Self-Harming (Non-suicidal and Suicidal) Behavior Kynurenine pathway metabolites and suicidality Ketamine, Transcranial Magnetic Stimulation, and Depression Specific Yoga and Mindfulness Based Cognitive Therapy in Management of Treatment Resistant Depression: Review and Some Data on Efficacy Potential of Glutamate-Based Drug Discovery for Next Generation Antidepressants Challenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved Therapeutics Pharmacological approaches to the challenge of treatment-resistant depression The role of inflammation in suicidal behaviour Glial abnormalities in substance use disorders and depression: does shared glutamatergic dysfunction contribute to comorbidity?Review of pharmacological treatment in mood disorders and future directions for drug development.Antidepressant actions of ketamine: from molecular mechanisms to clinical practice Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date Ketamine for treatment-resistant unipolar depression: current evidence Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy Digital Suicide Prevention: Can Technology Become a Game-changer?Ketamine: 50 Years of Modulating the Mind R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects Time-dependent metabolomic profiling of Ketamine drug action reveals hippocampal pathway alterations and biomarker candidates GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects.Acute D-serine treatment produces antidepressant-like effects in rodents Remodeling of axo-spinous synapses in the pathophysiology and treatment of depression.The mood stabilizer lithium potentiates the antidepressant-like effects and ameliorates oxidative stress induced by acute ketamine in a mouse model of stress Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants.Animal models to improve our understanding and treatment of suicidal behavior Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds.Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression Ketamine as a potential treatment for suicidal ideation: a systematic review of the literature Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex.Existing and novel biological therapeutics in suicide prevention.Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety.Baseline vitamin B12 and folate levels do not predict improvement in depression after a single infusion of ketamine.Multiple levels of impaired neural plasticity and cellular resilience in bipolar disorder: developing treatments using an integrated translational approach A randomized controlled trial of intranasal ketamine in major depressive disorder.Glutamatergic modulators: the future of treating mood disorders?Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics Circadian dysregulation of clock genes: clues to rapid treatments in major depressive disorder.

P2860

Q21129480-B9CC5C8E-09FA-4DB4-B283-C049D9650303 Q24617166-B1025176-FC6E-4D2D-8153-A83E0983EEEE Q24629398-F95AB88C-C112-47CF-BE5D-522137EC06D1 Q26766469-015120CA-6F05-44B6-9A8E-72DCDF8BA224 Q26773067-7031C6B8-1B78-4133-A9D5-73EA625FB321 Q26778251-F2693989-8193-437C-8B6B-1020ACC01067 Q26782274-1CFEED1F-C3C1-4713-88D5-353F2FE33862 Q26782997-3BEA7E4E-3DD3-48AF-87C6-75B1F3A50057 Q26798241-78F815E9-13F1-46C7-81B4-C552F1DA6945 Q26800426-574F56FD-4020-473C-85A6-590E660E6201 Q26829556-95EFC5F6-2A6C-4719-A3C5-8B1A75E3DABC Q26853509-8D0655B6-6AA8-4695-9A58-CEC216C1DBDF Q26995879-482D4065-FEA3-4934-B6DA-7244285053D6 Q27004490-FDF925AF-E3D0-47C4-BEC6-0524E713DDCD Q27004508-A5C7DFCF-6145-4442-8694-DB8B00FFB042 Q27024227-7E6DC6EF-BC7F-43BF-B1D8-244CA66352D3 Q28072625-9B344601-78A2-45DE-850C-C8D01EACA333 Q28077524-3208372D-0A95-4F22-B6A0-5AF75BCF6580 Q28266846-EB00C1AC-A9DD-489D-AAF8-12E4DEFD2922 Q30423149-6D93E07A-A40F-4946-B24C-717E3C86F020 Q30440925-7250435E-EA0B-44F0-89DA-47E6B4975EB9 Q30505292-CA6C46DA-266A-40FD-800F-525D38ABF455 Q30572014-FAD07D81-7248-48E0-80E8-2293288C98BA Q30651146-2F509008-8524-42ED-93FB-7D9C4C36D65A Q30711088-1C9CC6E1-57E1-4868-BC8D-4B996EE7F758 Q33604879-A8203E93-3333-48B8-A9EF-103A65039D59 Q33635653-B48BF94D-F0E7-4DA9-A725-461C4E4C49B2 Q33684538-96EB5869-1D19-491E-9E28-AADF62CB8EDC Q33874459-7E436DA6-A781-4639-B762-B8EA28B0D7F8 Q33956313-0828EAF7-F825-4EC7-924E-6776CCF4FA4A Q34043478-2A52C110-C461-45DC-814E-AE582D080E5E Q34061150-0D1AD889-2137-45A2-82E9-437F452E85DA Q34085866-7BBDD645-8CCE-4539-9743-93D7E0554280 Q34177760-00E0B9A2-7913-40D2-BEBF-0CD09A0FB4C3 Q34241455-7DA4EE24-C235-4EF7-A265-AD4916A5F566 Q34268501-566E44D8-21B9-4859-A3B6-C5C113F2C4BD Q34288196-9DFF2C3E-B1C4-44E0-8E2B-F5545DDC6234 Q34398007-1011004B-9D85-4BF0-912F-4A5F88E8E3BD Q34444632-D1492A6B-21B1-45EC-B85E-1CB06BE4C2CA Q34445122-FD327292-82A1-4105-9D58-1BB1BCEF06FF

P2860

Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder

http://www.wikidata.org/entity/Q34451408

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Rapid resolution of suicidal i ...... tant major depressive disorder

@ast

Rapid resolution of suicidal i ...... tant major depressive disorder

@en

Rapid resolution of suicidal i ...... tant major depressive disorder

@nl

type

label

Rapid resolution of suicidal i ...... tant major depressive disorder

@ast

Rapid resolution of suicidal i ...... tant major depressive disorder

@en

Rapid resolution of suicidal i ...... tant major depressive disorder

@nl

prefLabel

Rapid resolution of suicidal i ...... tant major depressive disorder

@ast

Rapid resolution of suicidal i ...... tant major depressive disorder

@en

Rapid resolution of suicidal i ...... tant major depressive disorder

@nl

P1433

Q34451408-99426275-DB59-4CE7-BC6B-F05E7D683D0F

P1476

Q34451408-10CAFE4D-C7E6-4B2D-977D-C13B66C86900

P2093

Q34451408-1DA3E929-B1A8-4A1A-9DEE-A5F6086C1967

Q34451408-74BBCC01-5A32-458A-B581-5291FA39D72A

Q34451408-7FD6594D-9F65-4E42-AA15-260F7B55EED3

Q34451408-837B60D6-2A48-4FD5-80FA-2DF4E27AE1EB

Q34451408-CC8902F6-A30C-436B-985D-4BAFBF1191E3

P2860

Q34451408-0DE3F8E3-035A-424D-B2D1-52F2A1B4F38C

Q34451408-0EAB3C31-010D-4D0C-A542-48A15ECC4824

Q34451408-168D2C57-4EFE-4CAB-A24B-AD09973F1E89

Q34451408-22366653-4AD4-4C30-B64B-7715E0CCBEF9

Q34451408-23941793-47D0-48B6-B880-867E718DDDAD

Q34451408-286011CB-5527-4230-A01E-5B95A447E2FA

Q34451408-29ABEFEB-81D1-4F9E-9DBC-23628E186D80

Q34451408-36ACCF20-66A5-49DF-BA3C-EC64B8900B23

Q34451408-3E510C04-12E9-4E09-8E0D-DE7D3D9397CD

Q34451408-53A275C7-42CE-41D6-9071-39E03BDD86DF

P304

Q34451408-05D1A14E-5D22-409E-A91D-580A003596DD

P31

Q34451408-43C6596D-BCC4-4A26-8A70-7E199C36CBD9

P356

Q34451408-5A4EBEEE-13F0-4F60-A83E-46F43F20956B

P433

Q34451408-39745B45-28A1-4A84-A5AC-974872DB126A

P478

Q34451408-4DDEB88F-8ECC-4DF8-84E0-54CF1FCCD672

P50

Q34451408-59176C28-AA98-4A42-A846-1BDBD5BF11D4

Q34451408-65BC85EA-4882-46F1-9825-353D7496D48B

Q34451408-8FF4E4A4-ABE1-47EE-8EA8-8ACAF2075D7F

P577

Q34451408-8680BCF4-9296-43C1-829F-056C6CD72A48

P698

Q34451408-E9579A6C-196E-4691-A043-9578BFE15EE7

P921

Q34451408-04E35483-3AE1-43FE-8EAA-3CB441D5F4F2

Q34451408-51A66223-CBAD-402A-B5D9-1200534FDFD6

Q34451408-67E3C705-ABDA-4AB0-B21C-F6B046067898

Q34451408-BAB2E41B-F1CE-40FA-AB10-3E26485DF0E9

Q34451408-FDB26F3B-4E9E-46A1-A54D-8EB28DB1BD47

P932

Q34451408-D7731360-8D49-4D3B-94DB-6C3D786D45F7

P356

JCP.09M05327BLU

P1433

The Journal of Clinical Psychiatry

P1476

Rapid resolution of suicidal i ...... tant major depressive disorder

@en

P2093

Carlos A Zarate

http://www.w3.org/2001/XMLSchema#string

David A Luckenbaugh

http://www.w3.org/2001/XMLSchema#string

Lobna A Ibrahim

http://www.w3.org/2001/XMLSchema#string

Nancy E Brutsche

http://www.w3.org/2001/XMLSchema#string

Rezvan Ameli

http://www.w3.org/2001/XMLSchema#string

P2860

Two-Year Randomized Controlled Trial and Follow-up of Dialectical Behavior Therapy vs Therapy by Experts for Suicidal Behaviors and Borderline Personality Disorder

A rating scale for depression

Psychometric properties and clinical utility of the Scale for Suicidal Ideation (SSI) in adolescents

Assessment of suicidal intention: the Scale for Suicide Ideation

Genetic markers of suicidal ideation emerging during citalopram treatment of major depression

Cognitive therapy for the prevention of suicide attempts: a randomized controlled trial

A new depression scale designed to be sensitive to change

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

Relationship between antidepressants and suicide attempts: an analysis of the Veterans Health Administration data sets.

Antidepressants and the risk of suicidal behaviors.

P304

1605-1611

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4088/JCP.09M05327BLU

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

71

http://www.w3.org/2001/XMLSchema#string

P50

Rodrigo Machado-Vieira

Nancy Diazgranados

P577

2010-07-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20673547

http://www.w3.org/2001/XMLSchema#string

P921

suicide prevention

suicidal ideation

P932

3012738

http://www.w3.org/2001/XMLSchema#string